Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
231.50    -5.00 (-2.11%)
Bid:
232.50
Ask:
235.50
Spread: 3.00 (1.29%)
Market Cap: £135.05m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

28 Sep 2011 17:09

RNS Number : 1385P
Gleeson(M J)Group PLC
28 September 2011
 

M J GLEESON GROUP PLC (the "Company")

 

28 September 2011

 

Notification of transactions by Directors and Persons Discharging Management Responsibilities ("PDMRs")

 

Pursuant to DTR3.1.4, the Company wishes to notify that on 26th September 2011, North Atlantic Smaller Companies Investment Trust Plc, Oryx International Growth Fund Limited and North Atlantic Value LLP acquired 3,369,425 ordinary shares at a purchase price of £1.015 per Ordinary Share. Each of these entities is connected to Mr. Christopher Mills, a Director of the Company, whose previous and current shareholdings, including those held by Related Persons, are as follows:

 

 

PDMR/Director

Previous Holding

Shares Acquired

Total Now Held

Percentage of Issued Share Capital

 

Christopher Mills

 

11,081,215

 

3,369,425

 

14,450,640

 

27.42%

 

This notification is to be read in conjunction with the Form TR1 identifying the entities names above, notified to the London Stock Exchange on today's date.

 

Enquiries:

 

MJ Gleeson Group plc

A Martin

Chief Operating Officer

and Group Financial Director Tel: 01252 360300

 

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQVLFLFKFBBBV
Date   Source Headline
28th Jun 20197:00 amRNSTotal Voting Rights
10th Jun 20192:16 pmRNSDirector/PDMR Shareholding
10th Jun 20197:00 amRNSRe Directorate
31st May 20197:00 amRNSTotal Voting Rights
30th May 20197:00 amRNSHolding(s) in Company
22nd May 20197:00 amRNSNotice of Site Visit
10th May 201910:52 amRNSDirector/PDMR Shareholding
2nd May 20197:00 amRNSSmaller related party land purchase
30th Apr 20197:00 amRNSTotal Voting Rights
29th Apr 201912:25 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSStatement re press speculation
29th Mar 20197:00 amRNSTotal Voting Rights
7th Mar 201911:16 amRNSDirector/PDMR Shareholding
28th Feb 20197:00 amRNSTotal Voting Rights
14th Feb 20197:00 amRNSHalf-year Report
8th Feb 201911:20 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSTotal Voting Rights
8th Jan 20194:51 pmRNSDirector/PDMR Shareholding
7th Jan 20197:00 amRNSNotice of Results and Trading Update
31st Dec 20187:00 amRNSTotal Voting Rights
19th Dec 20184:35 pmRNSPrice Monitoring Extension
11th Dec 20189:16 amRNSDirector/PDMR Shareholding
7th Dec 201810:41 amRNSResult of AGM
6th Dec 20187:00 amRNSAGM Statement
30th Nov 20187:00 amRNSTotal Voting Rights
7th Nov 20189:50 amRNSDirector/PDMR Shareholding
5th Nov 20189:00 amRNSNotice of AGM
31st Oct 20187:00 amRNSTotal Voting Rights
10th Oct 20184:55 pmRNSPerformance Share Plan award to Directors/PDMRs
9th Oct 201812:01 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSTotal Voting Rights
17th Sep 20187:00 amRNSFinal Results
7th Sep 20189:50 amRNSDirector/PDMR Shareholding
31st Aug 20187:00 amRNSTotal Voting Rights
9th Aug 20187:00 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSTotal Voting Rights
9th Jul 20189:05 amRNSDirector/PDMR Shareholding
5th Jul 20187:00 amRNSTrading Update
29th Jun 20187:00 amRNSTotal Voting Rights
6th Jun 20183:14 pmRNSDirector/PDMR Shareholding
31st May 20187:00 amRNSTotal Voting Rights
10th May 20189:57 amRNSDirector/PDMR Shareholding
30th Apr 20187:00 amRNSTotal Voting Rights
13th Apr 201811:32 amRNSDirector/PDMR Shareholding
6th Apr 201811:45 amRNSDirector/PDMR Shareholding
29th Mar 20187:00 amRNSTotal Voting Rights
12th Mar 201810:00 amRNSNotice of Results
6th Mar 20186:22 pmRNSDirector/PDMR Shareholding
1st Mar 20188:57 amRNSHolding(s) in Company
28th Feb 20185:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.